4.7 Article

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Journal

ANNALS OF ONCOLOGY
Volume 21, Issue -, Pages v98-v102

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdq208

Keywords

-

Categories

Funding

  1. Novartis
  2. Pfizer
  3. Bayer
  4. Amgen
  5. Roche
  6. Pharmamar
  7. Eisai
  8. GlaxoSmithKline
  9. Infinity and Genentech
  10. Novartis Pharma

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available